Literature DB >> 33055081

Trajectories of COVID-19 information in the Annals of the Rheumatic Diseases: the first months of the pandemic.

Kim Lauper1,2, Johannes W J Bijlsma3, Gerd R Burmester4.   

Abstract

Entities:  

Keywords:  antirheumatic agents; biological therapy; communicable diseases; hydroxychloroquine; imported

Year:  2020        PMID： 33055081     DOI： 10.1136/annrheumdis-2020-219217

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  4 in total

1.  Spotlight on Early COVID-19 Research Productivity: A 1-Year Bibliometric Analysis.

Authors:  Panagiotis Giannos; Konstantinos S Kechagias; Konstantinos Katsikas Triantafyllidis; Matthew E Falagas
Journal:  Front Public Health       Date:  2022-05-31

2.  Realising early recognition of arthritis in times of increased telemedicine: the value of patient-reported swollen joints.

Authors:  Cleo Rogier; Bastiaan T van Dijk; Elisabeth Brouwer; Pascal H P de Jong; Annette H M van der Helm-van Mil
Journal:  Ann Rheum Dis       Date:  2021-01-07       Impact factor: 19.103

Review 3.  COVID-19 from a rheumatology perspective: bibliometric and altmetric analysis.

Authors:  Bohdana Doskaliuk; Roman Yatsyshyn; Iryna Klishch; Olena Zimba
Journal:  Rheumatol Int       Date:  2021-10-01       Impact factor: 2.631

4.  Discovering temporal scientometric knowledge in COVID-19 scholarly production.

Authors:  Breno Santana Santos; Ivanovitch Silva; Luciana Lima; Patricia Takako Endo; Gisliany Alves; Marcel da Câmara Ribeiro-Dantas
Journal:  Scientometrics       Date:  2022-01-16       Impact factor: 3.801
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.